ELISA Kit for Vasoactive Intestinal Peptide (VIP) Ver mas grande

ELISA Kit for Vasoactive Intestinal Peptide (VIP)

CC-CEA380Hu

Producto nuevo

48T, 96T, 96T×5, 96T×10, 96T×100

Más detalles

Por favor regístrese para ver el precio

Comprando este producto generará 6 Biopuntos. Su cesta contiene un total 6 Biopuntos puede ser convertido en un Biobonos Descuento 24.00EUR.


Añadir a Mis Favoritos

Hoja técnica

Size 96T
Storage Conditions -20°C
Shipping Conditions Entre 4°C y 8°C
Applications Enzyme-linked immunosorbent assay for Antigen Detection.
Detection Range 6.17-500pg/mL
Sensitivity The minimum detectable dose of this kit is typically less than 2.63pg/mL
Research Area Endocrinology
Organism species Homo sapiens (Human)
Alternative Names PHM27
Item Name Vasoactive Intestinal Peptide
Assay Length 2h
Method Competitive Inhibition
Sample Type Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
Formato 48T, <i>96T</i>, 96T×5, 96T×10, 96T×100
Test Principle This assay employs the competitive inhibition enzyme immunoassay technique. A monoclonal antibody specific to Vasoactive Intestinal Peptide (VIP) has been pre-coated onto a microplate. A competitive inhibition reaction is launched between biotin labeled V
Assay procedure summary 1. Prepare all reagents, samples and standards
UniProt ID P01282

Más información

Click here for manual in PDF

Click here for OD Image


CITATIONS
VIP gene variants related to idiopathic pulmonary arterial hypertension in Chinese population;Low levels of vasoactive intestinal peptide are associated with Chagas disease cardiomyopathy;CGRP and VIP Levels as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine;Increased VIP levels in peripheral blood outside migraine attacks as a potential biomarker of cranial parasympathetic activation in chronic migraine;Clinical study of electro-acupuncture treatment with different intensities for functional constipation patients;Aqueous Fraction of Beta vulgaris Ameliorates Hyperglycemia in Diabetic Mice due to Enhanced Glucose Stimulated Insulin Secretion, Mediated by Acetylcholine and GLP-1, and Elevated Glucose Uptake via Increased Membrane Bound GLUT4 Transporters;Effect of acupuncture on house dust mite specific IgE, substance P, and symptoms in persistent allergic rhinitis;Relationship between serum levels of VIP, but not of CGRP, and cranial autonomic parasympathetic symptoms: A study in chronic migraine patients;No Change in Interictal PACAP Levels in Peripheral Blood in Women With Chronic Migraine;Using the "target constituent removal combined with bioactivity assay" strategy to investigate the optimum arecoline content in charred areca nut.;Salivary neuropeptides, stress, and periodontitis;Home-Based Transcutaneous Neuromodulation Improved Constipation via Modulating Gastrointestinal Hormones and Bile Acids;Vasoactive intestinal peptide degradation might influence Interleukin-17 expression in cardiac chagasic patients;Serum CGRP, VIP, and PACAP usefulness in migraine: a case–control study in chronic migraine patients in real clinical practice;Anti-Inflammatory and Pro-Inflammatory Neuropeptides in Dilative Cardiomyopathy are there Relations to Psychophysical Stress?;Significance of serum VIP and PACAP in multiple sclerosis: an exploratory case–control study;A clinical analysis on functioning pancreatic neuroendocrine tumors (focusing on VIPomas): a single-center experience;